The VACS Index Predicts Mortality in a Young, Healthy HIV Population Starting Highly Active Antiretroviral Therapy
Ionut Bebu(George Washington University), Brian K. Agan(Henry M. Jackson Foundation), Amy Weintrob, Amy C. Justice(Yale University), David Rimland(Emory University), Octavio Mesner, Mary Bavaro, Jason F. Okulicz(Gilead Sciences (United States)), Janet Tate(Yale University), Grace Macalino(Unknown), Anuradha Ganesan
Cited by 35
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada
|AIDS Research and Human Retroviruses|2015|335
Cumulative Incidence of Cancer Among Persons With HIV in North America
|Annals of Internal Medicine|2015|330